BioPharm International - May 2022

BioPharm International- May 2022

Issue link: https://www.e-digitaleditions.com/i/1467950

Contents of this Issue

Navigation

Page 20 of 35

BIOPHARMACEUTICAL ANALYTICAL DEVELOPMENT PROVEN EXPERTISE Your partner for regulatory-driven, phase-appropriate analytical programs tailored to your product. We oer Total Quality Assurance expertise, helping you to navigate the challenges of development, regulatory submission, and production. BIOLOGICS | CELL & GENE THERAPIES | OLIGONUCLEOTIDES | PHARMACEUTICALS • Experienced GLP/GCP and GMP laboratory services outsourcing partner • Global drug delivery expertise • Inhaled and nasal drug product development • Structural characterisation and physicochemical properties (ICH Q6B) • Clinical / preclinical bioanalysis (PK, ADA, Nab) and biomarker solutions • Method development/validation and GMP analysis • Comparability/biosimilar studies • ATMP analytical and CMC support • Cell based potency assays • ICH stability programs biopharma@intertek.com +44 (0)161 721 5247 intertek.com/pharmaceutical WEBINAR ON-DEMAND TOP 4 STEPS TO A PERFECT OUTSOURCING PARTNERSHIP We share lessons learned and discuss key considerations for a perfect partnership - based on decades of experience providing flexible outsourcing strategies to the world's most innovative biopharmaceutical organisations. Watch the video now by scanning the QR code.

Articles in this issue

Links on this page

Archives of this issue

view archives of BioPharm International - May 2022 - BioPharm International- May 2022